Market Overview

Akebia Therapeutics (NASDAQ: AKBA)

8.62 -0.01 (-0.12%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/20/19CitigroupInitiates Coverage OnNeutral9.0
9/07/18Morgan StanleyReinstatesEqual-Weight9.0
8/14/18Raymond JamesInitiates Coverage OnOutperform18.0
12/18/17PiperJaffrayInitiates Coverage OnOverweight26.0
12/07/17BTIG ResearchInitiates Coverage OnBuy30.0
10/05/17MizuhoInitiates Coverage OnBuy24.0
9/15/17RBC CapitalInitiates Coverage OnSector Perform17.0
11/15/16Aegis CapitalInitiates Coverage OnBuy18.0
9/29/16Brean CapitalAssumesBuy18.0
3/15/16H.C. WainwrightMaintainsBuy18.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter